Latest Breaking News On - புற்றுநோய் பதிவு - Page 13 : comparemela.com

Share A team of researchers from Monash University has discovered that a cardiac drug (carvedilol) could greatly reduce breast cancer progression, with those taking the drug at the time of diagnosis also much more likely to survive. Carvedilol is a beta-blocker used to manage cardiovascular disorders including hypertension and chemotherapy induced heart disease. In collaboration with a team from the Cancer Registry of Norway, the researchers investigated the effects of carvedilol in a large cohort of breast cancer patients (4,014) and found that if women happened to be taking carvedilol when they were diagnosed, they had a greater chance of survival than those not taking the drug.

South australiaBryan gillisErica sloanMonash universityNational health medical research councilMonash institute of pharmaceutical sciencesNational breast cancer foundationNational breast cancer foundation australiaCancer registryEuropean journalMonash institutePharmaceutical sciencesAssociate professor erica sloanProfessor erica sloanNational health medical researchதெற்கு ஆஸ்திரேலியா